The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancersZiyin Tian, Yun Yang, Yan Yang et al.|Heliyon|2022Cited by 23
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancerXi Chen, Hao Wang, Yun Yang et al.|Biochemical and Biophysical Research Communications|2016Cited by 18
A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cellsYun Yang, Shuyan Duan|Oncology Letters|2020Cited by 7
Synergistic effects of Nrf2 inhibitor, brusatol treatment in combination with lapatinib, a selective HER2 tyrosine kinase inhibitor in HER2-positive cancersZiyin Tian, Yun Yang|Research Square|2022Cited by 2